trastuzumab
Trastuzumab Deruxtecan for Breast Cancer NEJM
Trastuzumab Deruxtecan for Breast Cancer NEJM
Trastuzumab Deruxtecan for Breast Cancer NEJM trastuzumab The story of trastuzumab begins with Axel Ullrich's dedication to the concept that receptor tyrosine kinases must be the key to many human trastuzumab Possible Side Effects of Trastuzumab · Heart Problems · Infusion-Related Side Effects · Lung Problems · Low White Blood Cell Count (Leukopenia
trastuzumab Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB
trastuzumab Trastuzumab side effects · heart problems; · nausea, diarrhea, weight loss; · headache; · trouble sleeping, feeling tired; · low blood cell For women with HER2-positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments Treatment with trastuzumab